tiprankstipranks
Trending News
More News >
Angelalign Technology Inc. (HK:6699)
:6699
Hong Kong Market
Advertisement

Angelalign Technology Inc. (6699) AI Stock Analysis

Compare
5 Followers

Top Page

HK:6699

Angelalign Technology Inc.

(6699)

Rating:63Neutral
Price Target:
HK$60.00
▲(2.83%Upside)
Angelalign Technology Inc. shows strong growth potential with a solid balance sheet, but volatile profitability and a high P/E ratio suggest caution. Mixed technical indicators and weak valuation weigh down the overall score.

Angelalign Technology Inc. (6699) vs. iShares MSCI Hong Kong ETF (EWH)

Angelalign Technology Inc. Business Overview & Revenue Model

Company DescriptionAngelalign Technology Inc. (6699) is a Chinese company specializing in the design, manufacture, and sale of clear aligners used in orthodontic treatments. The company operates primarily within the healthcare and medical devices sectors, offering innovative dental solutions to both patients and dental professionals. Angelalign is known for its advanced technology and user-friendly products, aiming to improve oral health and aesthetics with minimally invasive procedures.
How the Company Makes MoneyAngelalign Technology Inc. generates revenue primarily through the sale of its clear aligner products. The company's revenue model is centered on providing these orthodontic solutions to dentists and orthodontists who then offer them to patients seeking teeth straightening treatments. Angelalign leverages advanced digital technology for designing and customizing aligners, which allows for a personalized approach to dental care. Additionally, the company benefits from strategic partnerships with dental professionals and clinics, enhancing its market reach and distribution network. By continuously investing in research and development, Angelalign ensures its products remain competitive and technologically advanced, which in turn supports its revenue growth. The company also engages in marketing and educational initiatives to increase awareness and adoption of its products among dental professionals and end-users.

Angelalign Technology Inc. Financial Statement Overview

Summary
Angelalign Technology Inc. shows strong revenue growth with a solid balance sheet, but challenges in profitability and cash flow management pose risks. The recent recovery in margins indicates a positive outlook.
Income Statement
75
Positive
Angelalign Technology Inc. displayed strong revenue growth from 2019 to 2024, with a noticeable increase in gross profit margin. However, volatile EBIT and net profit margins, especially the negative EBIT in 2023, indicate instability in profitability management. The recent improvement in 2024 suggests recovery and better cost control.
Balance Sheet
85
Very Positive
The company maintains a solid balance sheet with a low debt-to-equity ratio, signifying financial stability. The equity ratio is robust, indicating a strong equity base relative to its assets. Return on equity showed fluctuations but remains positive, highlighting effective use of equity capital.
Cash Flow
65
Positive
Operating cash flow has been positive but varied significantly over the years. Free cash flow turned negative in 2024, primarily due to increased capital expenditures, raising concerns about cash management. The operating cash flow to net income ratio is consistent, reflecting dependable cash earnings.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.96B1.48B1.27B1.27B816.53M
Gross Profit1.23B920.71M785.69M826.65M575.05M
EBITDA77.34M154.39M318.65M372.47M224.51M
Net Income88.42M53.48M213.78M285.85M150.69M
Balance Sheet
Total Assets4.95B4.76B4.49B4.14B1.21B
Cash, Cash Equivalents and Short-Term Investments3.19B3.44B3.65B3.63B877.58M
Total Debt14.48M65.28M28.20M30.29M14.17M
Total Liabilities1.44B1.35B884.01M826.11M712.47M
Stockholders Equity3.46B3.34B3.61B3.32B501.70M
Cash Flow
Free Cash Flow-76.78M51.28M51.48M241.95M366.61M
Operating Cash Flow123.48M165.87M146.87M441.71M408.28M
Investing Cash Flow-1.01B-981.71M-159.77M-182.05M-7.28M
Financing Cash Flow-207.73M-187.06M-193.61M2.52B-23.33M

Angelalign Technology Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price58.35
Price Trends
50DMA
55.80
Positive
100DMA
55.68
Positive
200DMA
57.67
Positive
Market Momentum
MACD
0.21
Negative
RSI
59.64
Neutral
STOCH
74.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6699, the sentiment is Positive. The current price of 58.35 is above the 20-day moving average (MA) of 55.43, above the 50-day MA of 55.80, and above the 200-day MA of 57.67, indicating a bullish trend. The MACD of 0.21 indicates Negative momentum. The RSI at 59.64 is Neutral, neither overbought nor oversold. The STOCH value of 74.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:6699.

Angelalign Technology Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
83
Outperform
€9.95B15.7018.36%0.39%7.13%13.39%
76
Outperform
$32.15B14.408.95%0.61%-3.09%0.67%
75
Outperform
HK$19.32B36.1328.81%0.02%14.99%31.70%
74
Outperform
€3.97B9.8015.04%4.07%6.05%1.32%
72
Outperform
HK$4.14B18.6211.24%1.27%11.23%20.39%
63
Neutral
HK$9.96B208.391.33%0.66%
60
Neutral
HK$16.95B5.65-7.44%2.90%11.55%-28.15%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:6699
Angelalign Technology Inc.
58.00
5.21
9.87%
HK:2276
Shanghai Conant Optical Co. Ltd. Class H
40.25
29.09
260.66%
HK:1501
Shanghai Kindly Medical Instruments Co., Ltd. Class H
23.55
-4.30
-15.44%
HK:1066
Shandong Weigao Group Medical Polymer Co
7.18
3.47
93.69%
HK:3600
Modern Dental Group Limited
4.23
0.19
4.60%
HK:9997
Kangji Medical Holdings Limited
8.42
3.04
56.45%

Angelalign Technology Inc. Corporate Events

Angelalign Technology Inc. Announces Board and Committee Appointments
Jun 24, 2025

Angelalign Technology Inc. has announced the composition of its board of directors and the establishment of key committees, including the Audit, Remuneration, and Nomination Committees. This strategic move is aimed at strengthening the company’s governance structure and enhancing its operational efficiency, potentially impacting its market positioning and stakeholder relations positively.

The most recent analyst rating on (HK:6699) stock is a Buy with a HK$69.55 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Secures Raw Material Supply for Clear Aligners
Jun 24, 2025

Angelalign Technology Inc. has announced that its subsidiary, Wuxi EA, has entered into a Product Purchase Cooperation Framework Agreement with Shanghai Kaihao, a company associated with a substantial shareholder of Angelalign. This agreement involves the purchase of raw materials for the production of clear aligners over an 18-month period, with set annual caps for purchases. The transactions are classified as continuing connected transactions under Hong Kong’s Listing Rules, requiring reporting and annual review but exempt from independent shareholder approval. This strategic move is expected to secure essential materials for Angelalign’s production, potentially enhancing its market position in the orthodontic industry.

The most recent analyst rating on (HK:6699) stock is a Buy with a HK$69.55 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Technology Inc. Grants RSUs to Boost Employee Motivation
Jun 24, 2025

Angelalign Technology Inc. has announced the grant of 736,920 restricted share units (RSUs) to 231 employees under its post-IPO RSU scheme, aimed at providing long-term motivation. The RSUs will vest in four tranches over four years, with performance targets and a clawback mechanism in place. This initiative is part of the company’s strategy to offer competitive remuneration and align employee incentives with company performance, potentially strengthening its market position and stakeholder confidence.

The most recent analyst rating on (HK:6699) stock is a Buy with a HK$69.55 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Technology Inc. Updates Nomination Committee Terms
Jun 24, 2025

Angelalign Technology Inc. has announced the amendment and restatement of the terms of reference for its Nomination Committee, effective from June 24, 2025. This move is part of the company’s ongoing efforts to enhance corporate governance and ensure a diverse and independent board structure, potentially impacting its operational efficiency and stakeholder confidence.

The most recent analyst rating on (HK:6699) stock is a Buy with a HK$84.95 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Technology Inc. Successfully Concludes Annual General Meeting with Key Resolutions Passed
May 23, 2025

Angelalign Technology Inc. announced the results of its Annual General Meeting held on May 23, 2025, where all proposed resolutions were passed with significant shareholder support. Key resolutions included the approval of financial statements, granting of mandates for share issuance and buybacks, re-election of directors, re-appointment of auditors, and the declaration of a special final dividend. The successful passing of these resolutions indicates strong shareholder confidence and positions the company for continued strategic growth and operational stability.

The most recent analyst rating on (HK:6699) stock is a Buy with a HK$84.95 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Technology Inc. Announces Key Leadership Changes
May 15, 2025

Angelalign Technology Inc. announced the resignation of Mr. Zhu Lingbo from his roles as senior vice president, board secretary, company secretary, and authorized representative, effective May 15, 2025. Mr. Zhu’s resignation is amicable, with no disagreements reported. In his place, Mr. Lee Leong Yin has been appointed as the new company secretary and authorized representative. Mr. Lee, nominated by Tricor Services Limited, brings over 14 years of experience in corporate secretarial services and holds relevant professional qualifications. This change in leadership is expected to maintain the company’s compliance with listing rules and support its corporate governance framework.

The most recent analyst rating on (HK:6699) stock is a Buy with a HK$86.00 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Technology Inc. Issues Supplemental Announcement on Connected Transactions
Apr 29, 2025

Angelalign Technology Inc. has issued a supplemental announcement regarding its continuing connected transactions under Rule 14A.60 of the Listing Rules. The announcement clarifies that the processing service fee for raw materials is fixed and was determined when the Processing Undertaking Agreement was established. This additional information does not alter the previous announcement’s content and maintains the validity of the original details.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 24, 2025